Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
95 studies found for:    Open Studies | "Nephritis"
Show Display Options
Rank Status Study
1 Recruiting Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Anifrolumab;   Drug: Placebo
2 Recruiting High Quality Evidence of Chinese Lupus Nephritis (HELP)
Condition: Lupus Nephritis
Intervention: Other: No Intervention
3 Recruiting Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: Tacrolimus;   Drug: Mycophenolate mofetil
4 Recruiting Mycophenolic Acid Pharmacokinetics and Pharmacogenomics in Lupus Nephritis
Condition: Lupus Nephritis
Intervention:
5 Recruiting Comparison Between Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) for Induction of Remission in Lupus Nephritis
Condition: Lupus Nephritis
Intervention: Drug: Tacrolimus vs. Mycophenolate mofetil for Induction Therapy in Lupus Nephritis
6 Recruiting A Study to Compare the Efficacy and Safety of Tacrolimus Capsules and Cyclophosphamide Injection in Treatment of Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: Tacrolimus capsules;   Drug: Cyclophosphamide injections;   Drug: Prednisone
7 Recruiting ACTHar in the Treatment of Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: CellCept;   Drug: ACTHar gel
8 Recruiting Weaning of Immunosuppression in Nephritis of Lupus
Condition: Nephritis of Lupus
Interventions: Drug: mycophenolate mofetil or azathioprine;   Other: immunosuppressive treatment discontinuation
9 Recruiting Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Placebo plus standard therapy;   Biological: Belimumab 10 mg/kg plus standard therapy;   Drug: Standard therapy
10 Recruiting Xolair (Omalizumab) for Treatment of Drug-induced Acute Tubulointerstitial Nephritis (AIN)
Condition: Acute Interstitial Nephritis
Interventions: Drug: Omalizumab;   Drug: Prednisone
11 Recruiting Rituximab and Belimumab for Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Rituximab;   Drug: Cyclophosphamide;   Drug: Prednisone;   Drug: Methylprednisolone;   Drug: Diphenhydramine;   Drug: Acetaminophen;   Biological: Belimumab
12 Not yet recruiting Iguratimod as Treatment for Refractory Lupus Nephritis
Condition: Lupus Nephritis
Intervention: Drug: Iguratimod
13 Recruiting A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: Mizoribine (MZR);   Drug: Cyclophosphamide (CTX)
14 Recruiting Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: BI 655064 dose 1;   Drug: BI 655064 dose 2;   Drug: BI 655064 dose 3;   Drug: Placebo
15 Recruiting Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Ixazomib in Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: Ixazomib;   Drug: Placebo
16 Recruiting A Study to Evaluate the Safety and Efficacy of Obinutuzumab Compared With Placebo in Participants With Lupus Nephritis (LN)
Condition: Lupus Nephritis
Interventions: Drug: Mycophenolate Mofetil/Mycophenolic Acid;   Drug: Obinutuzumab;   Other: Placebo;   Drug: Methylprednisolone;   Drug: Prednisone
17 Recruiting Interest to Perform a Renal Biopsy Early in the Course of the Henoch-Schoenlein Nephritis
Condition: Henoch Schönlein Nephritis
Intervention: Other: kidney biopsy
18 Not yet recruiting Iguratimod as Treatment for Active Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: Iguratimod;   Drug: Cyclophosphamide;   Drug: Azathioprine
19 Recruiting Aurinia Renal Response in Active Lupus With Orelvo (Voclosporin)
Condition: Lupus Nephritis
Interventions: Drug: Voclosporin;   Drug: Placebo Oral Capsule
20 Recruiting The Effect of Mycophenolate Mofetil and Cyclophosphamide on the Lymphocyte Subsets in Patients With Proliferative Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: MMF-MMF;   Drug: CTX-AZA

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.